Is this your brand? Claim it — free, and takes a minute with your work email.

Overview

Tagline Brand's website · 2026-10-04

Transforms routine retinal OCT data into actionable Biologic Intelligence using advanced image-derived biomarkers, revealing underlying biologic disease drivers. It operates on existing OCT infrastructure without requiring new scanners or changes to clinical workflow, enabling earlier detection and precision remediation.

Description Brand's website · 2026-10-04

Ascento CDA is an AI-powered platform for Biologic Intelligence that transforms routine retinal OCT data into actionable insights for earlier intervention in chronic diseases. It aims to help healthcare organizations detect biologic activity driving deterioration earlier to improve patient prioritization and provide more timely care.

Offerings

Core capabilities Brand's website · 2026-10-04

  • The Ascento Biologic Intelligence Platform
  • IICM™ (Inflammatory
  • Immunologic & Cognitive Mapping Platform)

Pricing Brand's website · 2026-10-04

Value-based healthcare model (designed for value-based care)

Audience

Target industry Brand's website · 2026-10-04

Population health organizations, healthcare providers, Accountable Care Organizations (ACOs), Payers. Focuses on clinical indications such as cognitive decline, diabetes progression, cardiovascular disease, chronic kidney disease, biologic aging, and inflammatory/immune-mediated diseases.

Is this your business?

The information above is publicly sourced — assembled by Optimly from Ascento Cda's website and public pages.

Claim this profile to publish your own verified Business Profile and speak for Ascento Cda across the index.

Claim Ascento Cda — free →

Page last updated 2026-10-17.